Influenza outbreak

RECENT NEWS  Jun 13  Comment 
LONDON (dpa-AFX) - Valneva announced that GlaxoSmithKline (GSK) in collaboration with one of its partners has for the first time supplied pre-pandemic influenza vaccines based on Valneva's EB66 cell line. Valneva granted an exclusive...
MedPage Today  May 25  Comment 
(MedPage Today) -- Egg-free product hits four influenza strains  May 24  Comment 
BASEL (dpa-AFX) - Seqirus, part of CSL Limited (CSL.AX), said that the US Food and Drug Administration has approved Flucelvax Quadrivalent or Influenza Vaccine, the first four-strain, cell culture-derived, inactivated seasonal influenza vaccine...
The Hindu Business Line  May 9  Comment 
The re-surfacing of bird flu or avian influenza (H5N1) in Bidar district of Karnataka has triggered concerns among poultry farm owners in the State and neighbouring Telangana. Confirming the outbreak ...
Forbes  Apr 21  Comment 
Could a health nut fit enough for long flamboyant performances be taken down by influenza in his mid-50s? Many strains of flu are most dangerous to infants and the elderly, but recently the Northern Hemisphere has seen a resurgence of a strain...
Insurance Journal  Mar 21  Comment 
One of the nation’s largest egg farms, which lost millions of hens in last year’s bird flu outbreak, is defending itself against legal action by the state over a wastewater spill that fouled 18 miles of stream in northwest Iowa …
The Hindu Business Line  Mar 9  Comment 
Kuwait has re-imposed the ban on import of Indian poultry products following the recent outbreak of avian influenza or bird flu in the north-eastern state of Tripura. The Department of Animal Hu...  Feb 8  Comment 
Bird flu restrictions have had the counter-intuitive effect of boosting China's chicken demand, as it struggles to source breeding stocks  Feb 8  Comment 
LONDON (dpa-AFX) - Valneva SE said that it has signed a new R&D collaboration agreement with GlaxoSmithKline (GSK, GSK.L) for the development of EB66-based Influenza vaccines. As per the agreement, Valneva will conduct an R&D program on behalf of...


Influenza, or the flu, is a common infectious disease, which can be deadly to individuals with compromised immune systems (the very young, the very old, and those with conditions such as AIDS or Cancer). However, occasionally particularly virulent strains of influenza break out that can be threatening on a much larger scale -- such as the flu epidemic of 1918 and, more recently, concerns that H5N1 "Bird Flu" or H1N1 "Swine Flu" could mutate into a highly-infectious and deadly virus. A number of pharmaceutical companies make treatments for the flu and benefit from the fear of a flu outbreak.

  • Roche Pharmaceuticals makes Tamiflu, an antiviral pill to treat the flu. In 2005, amid concerns that bird flu might pose a large threat during the winter flu season, many national governments began stocking up on Tamiflu. Chugai pharmaceuticals sells Tamiflu in Japan.
  • Novartis AG (NVS), through its acquisition of Chiron in 2006, supplies much of the traditional flu vaccine supply to the United States.
  • AstraZeneca (AZN), through recently acquired MedImmune, manufactures 'FluMist', a novel flu vaccine that is delivered via an intranasal spray rather than via an injection.

Companies with treatments for H1N1, or "Swine Flu"

In April 2009, a novel flu virus, known as "Swine Flu" because it was believed to have originated in pigs, started infecting humans. By April 28th, there were 1,300 confirmed cases of the flu, known by its scientific designation H1N1, in Mexico, and a handful in the U.S. and other parts of the world.

According to preliminary test done by the US Center for Disease Control, Roche Pharmaceuticals (RHHBY)'s Tamiflu and GlaxoSmithKline (GSK)'s Relenza are active against H1N1, although many older drugs are not. [1]


  1. Investors buy up shares of flu drug makers, New York Times, April 27th 2009.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki